3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
4
Urothelial Carcinoma of the Bladder
1
Squamous Cell Carcinoma of Head and Neck
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Ganglioneuroblastoma
1
Carcinoma
1
Brain Neoplasms
1
Interventions
Gemcitabine
6
Mitomycin
4
erdafitinib
3
viscum album peptide
1
pirarubicin
1
hydroxycamptothecinum
1
durvalumab
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Magnetic Resonance Spectroscopy
1
Injections
1
Epirubicin
1
Cystoscopy
1
BCG Vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Transurethral Resection of Bladder
×
30 days
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled